Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Int J Nanomedicine ; 7: 607-21, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22346354

RESUMO

The aim of vaccination is to induce appropriate immunity against pathogens. Antibody-mediated immunity is critical for protection against many virus diseases, although it is becoming more evident that coordinated, multifunctional immune responses lead to the most effective defense. Specific antibody (Ab) isotypes are more efficient at protecting against pathogen invasion in different locations in the body. For example, compared to other Ab isotypes, immunoglobulin (Ig) A provides more protection at mucosal areas. In this study, we developed a cationic lipopolymer (liposome-polyethylene glycol-polyethyleneimine complex [LPPC]) adjuvant that strongly adsorbs antigens or immunomodulators onto its surface to enhance or switch immune responses. The results demonstrate that LPPC enhances uptake ability, surface marker expression, proinflammatory cytokine release, and antigen presentation in mouse phagocytes. In contrast to Freund's adjuvant, LPPC preferentially activates Th1-immunity against antigens in vivo. With lipopolysaccharides or CpG oligodeoxynucleotides, LPPC dramatically enhances the IgA or IgG2A proportion of total Ig, even in hosts that have developed Th2 immunities and high IgG1 serum titers. Taken together, the results demonstrate that the LPPC adjuvant not only increases the immunogenicity of antigens but also modulates host immunity to produce an appropriate Ab isotype by combining with immunomodulators.


Assuntos
Adjuvantes Imunológicos/farmacologia , Formação de Anticorpos/efeitos dos fármacos , Switching de Imunoglobulina/efeitos dos fármacos , Imunoglobulina G/biossíntese , Lipossomos/farmacologia , Polietilenoglicóis/farmacologia , Polietilenoimina/análogos & derivados , Adjuvantes Imunológicos/química , Análise de Variância , Animais , Apresentação de Antígeno/efeitos dos fármacos , Antígenos CD/metabolismo , Diferenciação Celular/efeitos dos fármacos , Linhagem Celular , Chaperonina 60/farmacologia , Citocinas/metabolismo , Feminino , Humanos , Lipossomos/química , Glicoproteínas de Membrana/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Fagócitos/efeitos dos fármacos , Fagócitos/metabolismo , Polietilenoglicóis/química , Polietilenoimina/química , Polietilenoimina/farmacologia , Baço/citologia , Linfócitos T/efeitos dos fármacos , Linfócitos T/imunologia
2.
Biochem Biophys Res Commun ; 397(2): 283-9, 2010 Jun 25.
Artigo em Inglês | MEDLINE | ID: mdl-20580690

RESUMO

Helicobacter pylori is a potent carcinogen associated with gastric cancer malignancy. Recently, H. pylori Heat shock protein 60 (HpHSP60) has been reported to promote cancer development by inducing chronic inflammation and promoting tumor cell migration. This study demonstrates a role for HpHSP60 in angiogenesis, a necessary precursor to tumor growth. We showed that HpHSP60 enhanced cell migration and tube formation, but not cell proliferation, in human umbilical vein endothelial cells (HUVECs). HpHSP60 also indirectly promoted HUVEC proliferation when HUVECs were co-cultured with supernatants collected from HpHSP60-treated AGS or THP-1 cells. The angiogenic array showed that HpHSP60 dramatically induced THP-1 cells and HUVECs to produce the chemotactic factors IL-8 and GRO. Inhibition of CXCR2, the receptor for IL-8 and GRO, or downstream PLCbeta2/Ca2+-mediated signaling, significantly abolished HpHSP60-induced tube formation. In contrast, suppression of MAP K or PI3 K signaling did not affect HpHSP60-mediated tubulogenesis. These data suggest that HpHSP60 enhances angiogenesis via CXCR2/PLCbeta2/Ca2+ signal transduction in endothelial cells.


Assuntos
Proteínas de Bactérias/metabolismo , Transformação Celular Neoplásica , Endotélio Vascular/microbiologia , Helicobacter pylori , Neovascularização Patológica/microbiologia , Receptores de Interleucina-8B/metabolismo , Movimento Celular , Proliferação de Células , Endotélio Vascular/metabolismo , Endotélio Vascular/patologia , Humanos , Neovascularização Patológica/metabolismo , Neovascularização Patológica/patologia
3.
Biochem Biophys Res Commun ; 392(2): 183-9, 2010 Feb 05.
Artigo em Inglês | MEDLINE | ID: mdl-20060384

RESUMO

Helicobacter pylori has been found to promote the malignant process leading to gastric cancer. Heat shock protein 60 of H. pylori (HpHSP60) was previously been identified as a potent immunogene. This study investigates the role of HpHSP60 in gastric cancer carcinogenesis. The effect of HpHSP60 on cell proliferation, anti-death activity, angiogenesis and cell migration were explored. The results showed that HpHSP60 enhanced migration by gastric cancer cells and promoted tube formation by umbilical vein endothelial cells (HUVECs); however, HpHSP60 did not increase cell proliferation nor was this protein able to rescue gastric cancer cells from death. Moreover, the results also indicated HpHSP60 had different effects on AGS gastric cancer cells or THP-1 monocytic cells in terms of their expression of pro-inflammatory cytokines, which are known to be important to cancer development. We propose that HpHSP60 may trigger the initiation of carcinogenesis by inducing pro-inflammatory cytokine release and by promoting angiogenesis and metastasis. Thus, this extracellular pathogen-derived HSP60 is potentially a vigorous virulence factor that can act as a carcinogen during gastric tumorigenesis.


Assuntos
Proteínas de Bactérias/metabolismo , Transformação Celular Neoplásica , Helicobacter pylori/patogenicidade , Neoplasias Gástricas/microbiologia , Anticorpos Antibacterianos/sangue , Proteínas de Bactérias/imunologia , Proteínas de Bactérias/farmacologia , Movimento Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Citocinas/metabolismo , Helicobacter pylori/metabolismo , Humanos , Neovascularização Patológica/induzido quimicamente , Neovascularização Patológica/microbiologia , Neoplasias Gástricas/induzido quimicamente
4.
Biochem Biophys Res Commun ; 388(2): 283-9, 2009 Oct 16.
Artigo em Inglês | MEDLINE | ID: mdl-19664598

RESUMO

Helicobacter pylori heat shock protein 60 (HpHsp60) was first identified as an adhesion molecule associated with H. pylori infection. Here we have analyzed the structure of HpHsp60 via amino acid BLAST, circular dichroism, and electrophoresis and the results indicate that most recombinant HpHsp60 molecules exist as dimers or tetramers, which is quite different from Escherichia coli Hsp60. Treatment of human monocytic cells THP-1 with HpHsp60 was found to up-regulate a panel of cytokines including IL-1alpha, IL-8, IL-10, IFN-gamma, TNF-alpha, TGF-beta, GRO, and RANTES. Carboxymethylated HpHsp60 molecules with a switched oligomeric status were able to further enhance NF-kappaB-mediated IL-8 and TNF-alpha secretion in THP-1 cells compared to unmodified HpHsp60 molecules. These results indicated that the oligomeric status of HpHsp60s might have an important role in regulating host inflammation and thus help facilitate H. pylori persistent infection.


Assuntos
Proteínas de Bactérias/química , Proteínas de Bactérias/imunologia , Chaperonina 60/química , Chaperonina 60/imunologia , Helicobacter pylori/metabolismo , Sequência de Aminoácidos , Proteínas de Bactérias/genética , Linhagem Celular , Chaperonina 60/genética , Cisteína/química , Citocinas/biossíntese , Escherichia coli/genética , Escherichia coli/metabolismo , Helicobacter pylori/genética , Helicobacter pylori/imunologia , Humanos , Dados de Sequência Molecular , Polímeros/metabolismo , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA